RBC Capital Reaffirms $45 Price Target on Palantir

Oct 28, 2025 1 min read Reproduced verbatim
Rating
Sell
Price target
$45
Implied downside
-76%
vs $189.18 prior close
RBC Capital and Palantir logos

RBC Capital analyst Rishi Jaluria reiterated on October 28, 2025, an ‘Underperform’ rating and $45 price target on Palantir.

“We maintain our Underperform rating and $45 price target on Palantir ahead of Q3 earnings cheduled for November 3th after market close.

We see unfavorable risk/reward. Shares of PLTR are up ~20% over the past three months (vs. ~4% for IGV).

Heading into Q3 earnings, among our RBC All-SaaS constituents, Palantir is one of three names we track trading >20x EV/CY26E revenue (see here).

We cannot rationalize why Palantir is the most expensive name in our software coverage.

Absent a substantial beat-and-raise quarter elevating the NT growth trajectory, valuation seems unsustainable.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note+2% PLTR $189.18 → $192.07 (Oct 7) · moving away from the target

This call at 6 months✗ Not reached in six months: PLTR closed at $138, 207% above the $45 target, but it moved the way the analyst expected.

Firm track recordRBC Capital reached 82% of its 39 scored targets within six months (#3 of 31 firms); on Palantir, 0 of 2. Accuracy ranking →

RBC Capital on Palantir · target history
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.